VoxNeuro has received Health Canada Class II Medical Device designation for its proprietary Cognitive Health Assessment Management Platform™ (CHAMP). VoxNeuro will begin rolling out the software as a medical device across its Canadian Test Centers. This news comes hot on the heels of VoxNeuro’s FDA registration for the distribution of CHAMP as a Class II […]
0 comments / 0 votes
07
Jul-2021
Jul-2021
A recent federal investment in a Hamilton-based, life science cluster has increased access to expertise and funds for innovative healthcare technology companies – like VoxNeuro. Synapse is a life science cluster that was launched by Hamilton’s regional innovation centre, the Innovation Factory. “Synapse was ready to make the introductions to help us build our network […]
0 comments / 0 votes